Catalyst Wire Dossier Catalyst Wire Dossier

NYPOZI TXID

FILGRASTIM-TXID · Tanvex BioPharma USA, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NYPOZI TXID, covering 2024-06-28 to 2024-06-28. Get the full timeline:

Most recent: FDA Approved: NYPOZI TXID — Original Application (Tanvex BioPharma USA, Inc.)

See pricing